March 3, 2016 — Vital Connect debuted the VitalPatch biosensor at the 2016 Healthcare Information and Management Systems Society (HIMSS) conference and exhibition, Feb. 29-March 4 in Las Vegas. With the global market for biosensors to monitor health projected to exceed $40 billion annually by 2020, the company is introducing the all-in-one, single-use, fully disposable wearable developed to support clinical decision-making.
Powered by Vital Connect’s proprietary VitalCore processor, the VitalPatch is the next evolution of Vital Connect’s U.S. Food and Drug Administration (FDA)-approved HealthPatch MD biosensor. The same continuous measurements available in HealthPatch MD are now included in a peel-and-stick, single-use device. The lightweight, wireless, adhesive patch continuously monitors and records single-lead electrocardiogram (ECG), heart rate, heart rate variability, respiratory rate, skin temperature, posture, step count and fall detection with clinical accuracy. Through the Vital Connect platform, care teams receive accurate data and notifications to make health decisions and enable timely interventions.
The device has a streamlined, flexible profile that is unobtrusive during a patient’s activities of daily living. Also, since the patch is fully disposable, there is no potential for cross-contamination and no need for the patient or clinical staff to manage reusable components.
With the VitalPatch, patients may be monitored at any location where continuous monitoring offers the opportunity for early detection of patient deterioration and early intervention by care teams.
For more information: www.vitalconnect.com
November 15, 2024 
